Flash and Glow Reaction Analyte Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting bacterial cells, especially drug-resistant strains like MRSA and CRE, are inefficient, costly, and prone to false positives/negatives due to the need for skilled personnel, lengthy processes, and contamination risks, and do not distinguish between live and dead cells.
Innovation Solution
The use of engineered transduction particles that bind to target cells and induce the production of detectable reporter molecules, allowing for accurate measurement of their presence through signal analysis without replication, enabling rapid and cost-effective detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If bacterial culture methods are used for identification, then sensitivity is improved, but detection time increases to two to three days or longer
Solution Approach 1:
The patent extracts and amplifies specific genetic sequences (16S rRNA genes) from bacterial samples using PCR technology, separating the detection process from traditional lengthy culture methods. This extraction of key identification markers enables rapid detection within hours rather than days, while maintaining high sensitivity through specific primer binding to conserved and variable regions of the bacterial genome
Solution Approach 2:
The patent performs preliminary amplification of target DNA sequences using PCR before detection. By pre-amplifying the bacterial genetic material in the sample, the method ensures sufficient target quantity for sensitive detection without requiring lengthy culture periods, thus resolving the contradiction between detection sensitivity and time efficiency
2Measurement precision
If traditional culturing methods are employed, then bacterial identification is achieved, but the risk of contamination increases leading to false positives
Solution Approach 1:
The patent replaces traditional mechanical culture-based identification methods with molecular biology techniques (PCR and sequence analysis). This substitution eliminates the need for open culture systems that are prone to contamination, as the PCR process occurs in closed tubes with specific primers that selectively amplify only target bacterial sequences, thereby reducing false positives while maintaining identification accuracy
Solution Approach 2:
The patent creates specific copies of target bacterial DNA sequences through PCR amplification using designed primers. These amplified copies serve as reliable templates for identification without requiring culture of live bacteria, thus eliminating contamination risks associated with culture methods while preserving the ability to accurately identify bacterial species through sequence analysis
3Measurement precision
If PCR methods with thermal cycling are used, then detection sensitivity is improved, but cost and complexity increase
Solution Approach 1:
The patent segments the PCR process into distinct functional components: specific primer design targeting conserved and variable regions of 16S rRNA genes, amplification conditions optimization, and sequential detection steps. This segmentation allows for standardized protocols and simplified instrumentation requirements, reducing overall complexity while maintaining high detection sensitivity through targeted amplification of bacterial genetic markers
4Measurement precision
If nucleic acid isolation methods are used, then bacterial detection is achieved, but the number of preparation steps increases requiring skilled personnel
Solution Approach 1:
The patent performs preliminary amplification of target DNA sequences using PCR before detection. By pre-amplifying the bacterial genetic material in the sample, the method ensures sufficient target quantity for sensitive detection without requiring lengthy culture periods, thus resolving the contradiction between detection sensitivity and time efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides accurate and rapid identification of bacterial cells, reducing the need for skilled handling and minimizing contamination risks, while distinguishing between live and dead cells, thus improving diagnostic efficiency and accuracy.
Implementation Method 1
the plurality of transduction particles are (i) engineered to include a nucleic acid molecule formulated to cause the one or more target cells to produce a plurality of reporter molecules suitable to generate a detectable luminescence signal
Data Source
Figure 1
Figure 2
Figure 3A~3F
AI summary
Accurate measurements of the presence or absence of a target cell in a sample are provided. For example, the sample can be mixed with a plurality of transduction particles capable of binding to the target cells, the transduction particles being engineered to include a nucleic acid molecule formulated to cause the target cells to produce a plurality of detectable reporter molecules once the particles bind to and deliver the nucleic acid molecules into the one or more target cells. A set of signal data points are received that are associated with a quantity of reporter molecules and the signal data points are analyzed to accurately detect target cells in the sample. A curve is generated from the data gathered and analysed for peaks, which are mathematically transformed into positive signal data points using Area ratio, relative variation of the relative light units (RLU) and a linear threshold. Systems and methods are disclosed.